eBangor

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

Pink, J. and Lane, S. and Pirmohamed, M. and Hughes D.A., (2011) Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses. British Medical Journal, 343. pp. 1-14. DOI: 10.1136/bmj.d6333

Full-text not available from this repository..
Item Type: Article
Subjects: Research Publications
Departments: College of Health and Behavioural Sciences > Institute of Medical & Social Care Research
Date Deposited: 09 Dec 2014 16:59
Last Modified: 23 Sep 2015 03:19
ISSN: 0959-535X
URI: http://e.bangor.ac.uk/id/eprint/1717
Identification Number: DOI: 10.1136/bmj.d6333
Publisher: Unknown
Administer Item Administer Item

eBangor is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.